Alan G Wynne MD

Endocrinology•Topeka, KS

Diabetes, Osteoporosis & Bone Metabolism Medicine, Pituitary Disorders & Neuroendocrinology, Thyroid

Endocrinologist at the Cotton-O'Neil Clinic in Topeka, KS

Join to View Full Profile

3520 SW 6th AveTopeka, KS 66606
Phone+1 785-368-9591

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1991
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1985 - 1988
University of Missouri-Columbia School of MedicineClass of 1985

Certifications & Licensure

KS State Medical License 1991 - 2025
MN State Medical License 1986 - 1991
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012

Clinical Trials

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
Completed
Phase 3
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2014 Feb 01
Terminated
Phase 4
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes Start of enrollment: 2014 Apr 01
Completed
Phase 2
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
COMPLETED
NA
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
Completed
Phase 3
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy Start of enrollment: 2016 Dec 01
Completed
Phase 2
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2017 May 24
Completed
Phase 2
A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes. Start of enrollment: 2020 Apr 30
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

270 citations
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 tr...
Stefano Del Prato, Steven E. Kahn, Imre Pavo, Govinda Weerakkody, Zhengyu Yang
Lancet. 2021-11-13
30 citations
Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo-controlled trial in patients with type 2 diabetes using metformin.
Juan P. Frias, Alan G. Wynne, Beata Matyjaszek-Matuszek, Dagmar Bartaskova, David A. Cox
Diabetes, Obesity & Metabolism. 2019-09-01
171 citations
THE GLUCAGONOMA SYNDROME : CLINICAL AND PATHOLOGIC FEATURES IN 21 PATIENTS
Robert A. Wermers, Vahab Fatourechi, Alan G. Wynne, Larry K. Kvols, Ricardo V. Lloyd
Medicine. 1996-03-01

Press Mentions

Can Your Apple Watch Diagnose Thyroid Issues?April 16th, 2018
'It Saved My Life': How a Smartwatch Stopped a Woman's Health CrisisApril 12th, 2018
This Woman's Apple Watch Helped Detect Her Severe Thyroid ProblemApril 12th, 2018